Fig. 7From: PD-L1 monoclonal antibody-decorated nanoliposomes loaded with Paclitaxel and P-gp transport inhibitor for the synergistic chemotherapy against multidrug resistant gastric cancersSystemic toxicity analysis of individual formulations in SGC7901/ADR tumors; a mice body weight analysis; b, c blood biochemical evaluation of serum levels of AST and ALT as a systemic toxicity parameters. *p < 0.05 and **p < 0.01 is the statistical difference between free PTX and PD-PTLP treated groupBack to article page